Skip to main content
. 2022 Apr 21;27(9):2670. doi: 10.3390/molecules27092670
ARTs Artemisinin and its derivatives
ACTs Artemisinin-based combination therapies
PMV Plasmepsin V
PfPMV Plasmodium falciparum Plasmepsin V
PvPMV Plasmodium vivax Plasmepsin V
PEXEL Plasmodium EXport ELement
IC50 Half maximal inhibitory concentration
LD50 Lethal dose of 50%
DARTS Drug Affinity Responsive Target Stability
DMSO Dimethyl sulfoxide